Sanofi-Aventis Acquires Pfizer’s Insulin Facility in Germany
14:02 PM | June 15, 2009 | Deepti Ramesh
Sanofi-Aventis (Paris) says it has acquired one of the world’s largest insulin plants at Frankfurt, Germany, from Pfizer for €30 million. Sanofi-Aventis aims to strengthen its insulin production...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.